44 related articles for article (PubMed ID: 26661712)
1. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma.
Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H
Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637
[TBL] [Abstract][Full Text] [Related]
2. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.
Nakamura E; Kozaki K; Tsuda H; Suzuki E; Pimkhaokham A; Yamamoto G; Irie T; Tachikawa T; Amagasa T; Inazawa J; Imoto I
Cancer Sci; 2008 Jul; 99(7):1390-400. PubMed ID: 18452558
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression and demethylation of gamma-synuclein in colorectal cancer, correlated with progression of the disease.
Ye Q; Zheng MH; Cai Q; Feng B; Chen XH; Yu BQ; Gao YB; Ji J; Lu AG; Li JW; Wang ML; Liu BY
Cancer Sci; 2008 Oct; 99(10):1924-32. PubMed ID: 19016751
[TBL] [Abstract][Full Text] [Related]
4. Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.
Nakagawa T; Pimkhaokham A; Suzuki E; Omura K; Inazawa J; Imoto I
Cancer Sci; 2006 Oct; 97(10):1070-4. PubMed ID: 16918994
[TBL] [Abstract][Full Text] [Related]
5. γ-Synuclein promotes proliferation and inhibits apoptosis of oral squamous cell carcinoma via JAK2/STAT5b signaling pathway.
Yang J; Ren Z; Wang F; Zheng J; Zhuang Z; Zeng Y
Am J Cancer Res; 2024; 14(5):2408-2423. PubMed ID: 38859859
[TBL] [Abstract][Full Text] [Related]
6. LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma.
Cela I; Caponio VCA; Capone E; Pinti M; Mascitti M; Togni L; Lo Muzio L; Rubini C; De Laurenzi V; Lattanzio R; Perrotti V; Sala G
Oral Dis; 2024 May; 30(4):2039-2050. PubMed ID: 37649401
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic Effects of 5-Azacytidine on Primary Tumour Cells and Cancer Stem Cells from Oral Squamous Cell Carcinoma: An In Vitro FTIRM Analysis.
Notarstefano V; Belloni A; Sabbatini S; Pro C; Orilisi G; Monterubbianesi R; Tosco V; Byrne HJ; Vaccari L; Giorgini E
Cells; 2021 Aug; 10(8):. PubMed ID: 34440896
[TBL] [Abstract][Full Text] [Related]
8. Uracil as a biomarker for spatial pyrimidine metabolism in the development of gingivobuccal oral squamous cell carcinoma.
Shaikh S; Basu S; Bag S; Chatterjee A; Datta S; Banerjee D; Manikantan K; Arun I; Arun P; Biswas NK; Maitra A; Mishra DK; Majumder PP; Dhar H; Mukherjee G
Sci Rep; 2024 May; 14(1):11609. PubMed ID: 38773214
[TBL] [Abstract][Full Text] [Related]
9.
Sorroche BP; Miranda KC; Beltrami CM; Arantes LMRB; Kowalski LP; Marchi FA; Rogatto SR; Almeida JD
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473236
[TBL] [Abstract][Full Text] [Related]
10. Synuclein Proteins in Cancer Development and Progression.
Zanotti LC; Malizia F; Cesatti Laluce N; Avila A; Mamberto M; Anselmino LE; Menacho-Márquez M
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371560
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of anoikis-associated gene SNCG as a prognostic biomarker in gastric cancer.
Li Y; Pan Q; Cheng M; Wu Z
Aging (Albany NY); 2023 Mar; 15(7):2541-2553. PubMed ID: 36996495
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Synuclein-
Yang J; Pan Y; Peng L; Zhang L; Zhao J; Zheng Z; Zheng J; Xu X; Zeng Y
Biomed Res Int; 2022; 2022():6534626. PubMed ID: 35434126
[TBL] [Abstract][Full Text] [Related]
13. Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy.
Hsu CC; Su YF; Tsai KY; Kuo FC; Chiang CF; Chien CY; Chen YC; Lee CH; Wu YC; Wang K; Liu SY; Shieh YS
Cancer Cell Int; 2020; 20():300. PubMed ID: 32669976
[TBL] [Abstract][Full Text] [Related]
14. SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway.
Zhang J; Liu XH; Li C; Wu XX; Chen YL; Li WW; Li X; Gong F; Tang Q; Jiang D
J Exp Clin Cancer Res; 2020 May; 39(1):79. PubMed ID: 32381034
[TBL] [Abstract][Full Text] [Related]
15. The anti-melanoma activity and oncogenic targets of hsa-miR-15a-5p.
Alderman C; Yang Y
RNA Dis; 2016; 3(4):. PubMed ID: 28286866
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway.
Ge Y; Xu K
Cancer Cell Int; 2016; 16():86. PubMed ID: 27895530
[TBL] [Abstract][Full Text] [Related]
17. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma.
Cheng JC; Chiang MT; Lee CH; Liu SY; Chiu KC; Chou YT; Huang RY; Huang SM; Shieh YS
J Dent Res; 2016 Apr; 95(4):439-45. PubMed ID: 26661712
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
19. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
